Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaplacide (KAF156) in uncomplicated malaria
NCT01753323Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ganaplacide in Plasmodium falciparum malaria, malaria, sponsored by Novartis. Started Mar 2013; status: completed.
02
Drugs
ganaplacide
03
Conditions
Plasmodium falciparum malariamalaria
Beyond the preview
Go deeper on NCT01753323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753323.